MicroRNAs (miRNAs) have emerged as critical regulators of gene expression. These small, non-coding RNAs are believed to regulate more than a third of all protein coding genes, and they have been implicated in the control of virtually all biological processes, including the biology of stem cells. The essential roles of miRNAs in the control of pluripotent stem cells were clearly established by the finding that embryonic stem (ES) cells lacking proteins required for miRNA biogenesis exhibit defects in proliferation and differentiation. Subsequently, the function of numerous miRNAs has been shown to control the fate of ES cells and to directly influence critical gene regulatory networks controlled by pluripotency factors Sox2, Oct4, and Nanog. Moreover, a growing list of tissue-specific miRNAs, which are silenced or not processed fully in ES cells, has been found to promote differentiation upon their expression and proper processing. The importance of miRNAs for ES cells is further indicated by the exciting discovery that specific miRNA mimics or miRNA inhibitors promote the reprogramming of somatic cells into induced pluripotent stem (iPS) cells. Although some progress has been made during the past two years in our understanding of the contribution of specific miRNAs during reprogramming, further progress is needed since it is highly likely that miRNAs play even wider roles in the generation of iPS cells than currently appreciated. This review examines recent developments related to the roles of miRNAs in the biology of pluripotent stem cells. In addition, we posit that more than a dozen additional miRNAs are excellent candidates for influencing the generation of iPS cells as well as for providing new insights into the process of reprogramming.
Introduction
The seminal finding that lin-4, and later let-7, are developmental regulators of Caenorhabditis elegans sparked the exciting discovery that a class of small RNAs plays critical roles in the regulation of gene expression (Lee et al., 1993; Reinhart et al., 2000) . Subsequently, homologs of let-7 were identified in higher organisms, including mammals and, soon thereafter, it was recognized that these small RNAs belong to a large family of noncoding RNAs known as microRNAs (miRNAs) (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001) . miRNAs have emerged as key regulators of gene silencing that act by targeting specific mRNAs for degradation or by suppressing their translation. Remarkably, miRNAs are believed to regulate more than a third of all protein coding genes, and they have been shown to directly influence virtually all biological processes, including stem cell self-renewal and lineage specification during development, as well as diseases, such as cancer (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2007; Kato and Slack, 2008; Liu et al., 2008; Stefani and Slack, 2008; Wang et al., 2008b; Cordes and Srivastava, 2009; Friedman and Jones, 2009) .
In this review, we discuss the varied roles played by miRNA in the maintenance of embryonic stem (ES) cell self-renewal and pluripotency. We also discuss several recent studies that have begun to probe the roles of miRNAs during the reprogramming of somatic cells into induced pluripotent stem (iPS) cells. Finally, we discuss why more than a dozen additional miRNAs are likely to influence the process of reprogramming. Not discussed in this review are studies dealing with miRNAs in adult stem cells. Readers interested in this topic are referred to several excellent reviews (Zhao and Srivastava, 2007; Lakshmipathy and Hart, 2008; Gangaraju and Lin, 2009; Li and Jin, 2010) . miRNA) transcripts in the nucleus are recognized and cleaved into ∼ 70-nucleotide precursor-miRNAs (pre-miRNAs) by a microprocessor complex, which contains RNase III enzyme Drosha and RNA binding protein DiGeorge syndrome Critical Region gene 8 (DGCR8) (Lee et al., 2002; Lee et al., 2003; Zeng and Cullen, 2003; Kim., 2005) . Pre-miRNAs are transported into the cytoplasm by Exportin 5, followed by Dicermediated processing into ∼ 22-nucleotide mature miRNA duplexes (Lee et al., 2003; Yi et al., 2003; Lund et al., 2004) . Like Drosha, Dicer functions in concert with RNA binding protein Transactivating Region Binding Protein (TRBP) (Chendrimada et al., 2005; Haase et al., 2005) . One of the miRNA duplex strands serves as a guide strand and is incorporated into the Argonaute-containing RISC complex, while the other strand is released and degraded (Maniataki and Mourelatos, 2005) . The eight-nucleotide seed sequence in the 5′ terminus of the miRNA guide strand is critical for target recognition, and the guide strand directs the RISC complex to target mRNA sequences (Brennecke et al., 2005; Lewis et al., 2005) . Target recognition by miRNA is often mediated by imperfect base pairing with a region that lies in the 3′ untranslated region (UTR) of mRNA. Imperfect base pairing with their targets enables miRNAs to target multiple genes simultaneously. Recent studies have demonstrated that miRNAs can also target regions outside of the 3′ UTR, such as regions in 5′ UTR and the amino acid coding sequence of mRNA (Lytle et al., 2007; Tay et al., 2008a) .
Roles of miRNAs in the establishment of the ES cell phenotype
ES cells have a unique ability to replicate indefinitely (selfrenewal), yet they are capable of forming all cell types of the body Fig. 1 . Schematic representation of the miRNA biogenesis. miRNA biogenesis involves both nuclear and cytoplasmic steps. Following transcription, pri-miRNAs are processed into pre-miRNAs by a microprocessor complex containing Drosha and DGCR8. Pre-miRNAs are exported from the nucleus into the cytoplasm by Exportin 5-RanGTP. In the cytoplasm, pre-miRNAs are processed into mature miRNA duplex by Dicer, which functions in concert with TRBP. One of the strands from the mature miRNA duplex, the guide strand, is loaded into the Argonaute-RISC complex. The guide strand then directs the RISC complex to mRNA target sequences to mediate gene silencing.
(pluripotency). These properties of ES cells, and their reprogrammed counterparts, iPS cells, offer immense potential for the field of regenerative medicine. However, before ES cells and iPS cells are used clinically, a thorough understanding of the mechanisms that control pluripotent stem cell identity would be extremely valuable. Recent work has demonstrated that miRNAs play key roles in controlling the fate of ES cells. Contribution of miRNA pathways to ES cell identity has been studied using Dicer null and DGCR8 null ES cells, which lack all mature miRNAs (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2007) . Dicer is necessary for maturation of both miRNAs and small interfering RNAs, whereas DGCR8 is not required for small interfering RNA processing (Denli et al., 2004; Gregory et al., 2004; Han et al., 2004; Landthaler et al., 2004; Wang et al., 2007) . Dicer null ES cells exhibit slow proliferation rates and defective differentiation (Kanellopoulou et al., 2005; Murchison et al., 2005) . When these cells are induced to differentiate in embryoid bodies, Oct4 expression is only partially decreased, and endodermal and mesodermal markers, which are typically expressed by differentiated ES cells, are not detectable (Kanellopoulou et al., 2005) . DGCR8 null ES cells also exhibit defective differentiation . When these cells were subjected to conditions that normally induce ES cell differentiation, they exhibited abnormal activation of multiple markers of differentiation, coupled with the inability to silence expression of pluripotency markers. DGCR8 null ES cells accumulate in the G1 phase of the cell cycle, indicating that DGCR8 is necessary for normal ES cell proliferation and cell cycle progression . Together, these studies demonstrated the requirement of mature miRNAs for the maintenance of ES cell self-renewal and pluripotency. Additionally, several independent studies have identified distinct miRNAs expressed in ES cells and their differentiated counterparts, reinforcing the role of ES cell-specific miRNAs in regulating ES cell identity (Houbaviy et al., 2003; Bar et al., 2008; Laurent et al., 2008) .
Convergence of miRNAs and a key ES cell gene regulatory network
Recently, significant progress has been made towards understanding the contribution of specific miRNAs in establishing the ES cell phenotype (summarized in Fig. 2 ). It is becoming evident that miRNAs are an integral part of the gene networks regulated by pluripotency factors Sox2, Oct4, and Nanog. Genome-wide binding assays of Sox2, Oct4, and Nanog demonstrated that these transcription factors cooccupy promoters of the majority of miRNAs that are preferentially expressed in mouse ES cells, including the miR-290 cluster and miR-302 cluster miRNAs (Marson et al., 2008) . Moreover, these transcription factors not only bind to the promoters of the miR-290 cluster and the miR-302 cluster, but they have also been shown to regulate the expression of these miRNAs (Barroso-delJesus et al., 2008; Card et al., 2008; Marson et al., 2008) .
It is becoming evident that the trio of Sox2, Oct4, and Nanog utilizes miRNAs to fine tune the expression of their target genes in ES cells. This is exemplified by the involvement of Sox2, Oct4, and Nanog in incoherent and coherent feed-forward regulatory networks, by activating expression of specific miRNAs, to modulate the levels of proteins, such as Lefty1 and DNA methyltransferases 3a and 3b (Dnmt 3a and Dnmt 3b), in ES cells (Marson et al., 2008) . Lefty1 participates in pluripotency regulating transcription networks (Nakatake et al., 2006) , whereas Dnmt 3a and Dnmt 3b are necessary for proper differentiation of ES cells when they are subjected to appropriate differentiation cues (Benetti et al., 2008; Sinkkonen et al., 2008) . Recently, two independent studies have investigated the mechanism responsible for the inability of Dicer null ES cells to silence the selfrenewal program when subjected to conditions that normally promote differentiation. These studies determined that the miR-290 cluster of miRNAs is required for expression of de novo DNA methyltransferases in ES cells, and that differentiation defects observed in Dicer null ES cells are due, at least in part, to incomplete and reversible silencing of Oct4 expression, resulting from improper promoter methylation (Benetti et al., 2008; Sinkkonen et al., 2008) .
In addition to the association of Sox2, Oct4, and Nanog with promoters of miRNAs that are preferentially expressed in ES cells, Sox2, Oct4, and Nanog also associate with the promoters of silenced tissue-specific miRNAs (Marson et al., 2008) . It has been suggested that binding of Sox2, Oct4, and Nanog to these tissue-specific miRNAs primes them for expression upon differentiation of ES cells; however, they are kept silent in ES cells due to the association of these miRNA genes with inhibitory polycomb repressor proteins (Marson et al., 2008) . In this regard, several tissue-specific miRNAs are involved in regulating the expression of critical pluripotency factors, and they induce differentiation when expressed in ES cells. For example, miR-296, miR-470, and miR-134, whose expression is upregulated upon retinoic acid induced differentiation of mouse ES cells, inhibit the expression of Sox2, Oct4, and Nanog in various combinations (Tay et al., 2008a,b) . In a related study, miR-145 has been shown to repress pluripotency in human ES cells by downregulating the expression of Sox2, Oct4, and Klf4 (Xu et al., 2009b) . These findings demonstrate that miRNAs are an integral part of the core ES cell transcriptional regulatory network and play important roles in regulating ES cell fate.
Role of miRNAs in ES cell-specific cell cycle structure
As discussed earlier, DGCR8 null mouse ES cells exhibit cell cycle defects. To extend these findings, Wang et al. screened a library of 266 mouse miRNAs for their ability to rescue the cell cycle defects of DGCR8 null ES cells . They determined that a subset of miRNAs, referred to as ES cell-specific cell cycle-regulating miRNAs (ESCC miRNAs) (miR-291a-3p, miR-291b-3p, miR-294, miR-295, and miR-302), can rescue the ES cell cycle defect. This occurs, at least in part, by promoting the G1-S transition. These workers also demonstrated that ESCC miRNAs exert their effect by suppressing the expression of multiple cyclin E-Cdk2 inhibitors, such as p21, Rbl2, and Lats2 .
To fully understand the roles played by miRNAs in ES cells, it is important to stress that mouse and human ES cells represent different stages of mammalian development (Brons et al., 2007; Tesar et al., 2007) . Consequently, it is likely that there are differences in the mechanisms that control the self-renewal of mouse and human ES cells. For instance, of the miRNAs belonging to the miR-290 and miR-302 clusters, miR-302 cluster miRNAs are expressed in both human and mouse ES cells; whereas, miR-290 cluster is only expressed in mouse ES cells (Kim et al., 2009c) . Furthermore, work with several miRNAs has only been conducted in human ES cells. For example, miR-520 cluster miRNAs, whose seed sequence is similar to miR-302 cluster miRNAs, have been shown to regulate important cellular functions in human ES cells, including cell proliferation and chromatin structure (Ren et al., 2009) . Another miRNA whose function has only been studied in human ES cells is miR-92b, which promotes the G1-S transition by repressing the Cdk inhibitor p57 (Sengupta et al., 2009 ). Interestingly, genome-wide transcription factor binding assays have demonstrated that pluripotency factors Sox2 and Oct4 associate with the promoter of miR-92b in mouse ES cells, suggesting direct regulation of miR-92b expression by Sox2 and Oct4 (Marson et al., 2008) , and also likely involvement of miR-92b in establishing the mouse ES cell phenotype.
Opposing roles of ESCC and let-7 miRNAs in the control of ES cell fate ESCC and let-7 family miRNAs have begun to emerge as important regulators of ES cell self-renewal, pluripotency, and differentiation (Melton et al., 2010) . ESCC and let-7 miRNAs represent major miRNAs expressed in ES cells and somatic cells, respectively (Marson et al., 2008) . Although mature let-7 is not expressed in ES cells, the let-7 promoter is bound by Sox2, Oct4, and Nanog (Marson et al., 2008) . In accordance with this finding, pri-let-7 transcripts are present at high levels in ES cells and depletion of Oct4 decreases the levels of pri-let-7 transcripts (Marson et al., 2008) . However, processing of pri-let-7 into mature let-7 is prevented by RNA binding protein Lin28. Lin28 inhibits both Drosha-mediated Viswanathan et al., 2008) and Dicer-mediated (Heo et al., 2008; Rybak et al., 2008) processing of pri-let-7 into mature let-7. Mature let-7, in turn, inhibits the expression of Lin28 (Rybak et al., 2008) . Thus, the negative feedback loop between Lin28 and let-7 has a major influence over ES cell fate. Lin28, apart from its role in preventing the generation of mature let-7, is necessary for proper ES cell proliferation, and also for efficient translation of Oct4 (Xu et al., 2009a; Qiu et al., 2010) . c-Myc, which is required for maintenance of ES cell self-renewal (Cartwright et al., 2005) , is also involved in a negative feedback regulatory loop with let-7. c-Myc, through an indirect mechanism involving transcriptional activation of Lin28, inhibits the biogenesis of mature let-7 (Chang et al., 2009) . Additionally, in lymphoma cells where expression of c-Myc leads to downregulation of let-7 expression, c-Myc has been shown to bind let-7 promoter, which suggest that c-Myc directly inhibits let-7 expression . Mature let-7, in turn, directly inhibits the expression of c-Myc (Kumar et al., 2007; Melton et al., 2010) . Using DGCR8 null ES cells, described above, Melton et al. demonstrated that ESCC and let-7 miRNAs play opposing roles in regulating the ES cell phenotype (Melton et al., 2010) . Specifically, they demonstrated that introduction of ESCC miRNAs into DGCR8 null ES cells rescued the cell cycle defect, whereas introduction of let-7 miRNAs induced DGCR8 null ES cells to differentiate.
The effects of let-7 in ES cells can be explained by its inhibitory effect on the expression of Lin28, c-Myc, Sall4 and downstream target genes of pluripotency factors, in particular Sox2, Oct4, and Nanog (Melton et al., 2010) . Additionally, let-7 also represses positive regulators of cell cycle, such as CDK6, CDC25A, and Cyclin D, in human cancer cells (Johnson et al., 2007) . Introduction of let-7 into wild-type ES cells failed to induce ES cells to differentiate, which suggests that ESCC miRNAs antagonize the effects of let-7 in ES cells (Melton et al., 2010) . The importance of ESCC miRNAs in regulating ES cell fate is further reinforced by the presence of a positive feedback loop between ESCC miRNAs and Myc. In this regard, ChIP-seq data have shown that c-Myc and n-Myc bind to the promoter of the miR-290 cluster, which expresses several ESCC miRNAs, suggesting direct activation of expression of these miRNAs by Myc . c-Myc has also been shown to induce, by an indirect mechanism, the expression of the miR-302 cluster, which codes for an ESCC miRNA . Moreover, the ESCC miRNA, miR-294, has been shown to indirectly activate the expression of c-Myc (Melton et al., 2010) .
Recently, c-Myc has been shown to bind to promoter regions of miR-141, miR-200, and miR-429 and to induce their expression in mouse ES cells ). Introduction of these c-Myc induced miRNAs into ES cells attenuated the differentiation of these cells in response to LIF withdrawal. The miR-17-92 cluster of miRNAs, whose expression is elevated in many cancers, are also enriched in ES cells, and have similar seed sequences to those of ESCC miRNAs (Laurent et al., 2008; Marson et al., 2008; Mendell., 2008; Wang et al., 2008b; Judson et al., 2009) . Additionally, c-Myc has been shown to induce the expression of the miR-17-92 cluster in tumor cells (O'Donnell et al., 2005) . However, the function of the miR-17-92 cluster in ES cells has not been investigated. The fact that miRNAs from the miR-17-92 cluster have seed sequences similar to those of ESCC miRNAs, and that c-Myc induces expression of both miR-17-92 and ESCC miRNAs, highlights the impact of c-Myc-regulated miRNAs on the self-renewal of stem cells (He et al., 2005; O'Donnell et al., 2005; Chen et al., 2008) .
Regulatory mechanisms involved in establishing the ES cell-specific miRNA profile
Although it is clear that miRNAs play critical roles in regulating the self-renewal and pluripotency of ES cells, much less is known about the molecular mechanisms that regulate miRNA expression in pluripotent stem cells. This will necessitate systematic identification and study of both functional core promoter/enhancer elements, and specific cis-regulatory elements involved in the regulation of miRNA expression in ES cells and differentiated cells. A recent study involving large scale identification of miRNA promoters in both human and mouse cells is an excellent starting point for characterizing individual miRNA promoters (Marson et al., 2008) . Recently, the miR-302 cluster promoter has been characterized and functionally validated in human ES cells (Barroso-delJesus et al., 2008; Card et al., 2008) . Specifically, it has been demonstrated that Sox2 and Oct4 bind the miR-302 promoter and are essential for expression of miR-302 miRNAs in human ES cells (Card et al., 2008) . Similar studies are warranted for miRNAs, such as the miR-290 cluster, miR-92b, miR-145, miR-134 and the let-7 cluster, that are known to play important functions in ES cell self-renewal and differentiation.
Biogenesis of miRNAs, which interfere with ES cell self-renewal and pluripotency, appears to be tightly regulated at multiple levels in ES cells. This is exemplified for let-7 miRNAs, whose biogenesis is controlled at both transcriptional and post-transcriptional levels. As noted above, c-Myc has been shown to transcriptionally repress let-7 expression in lymphoma cells , whereas Lin28 prevents processing of pri-let-7 to mature let-7 in ES cells (Heo et al., 2008; Newman et al., 2008; Rybak et al., 2008; Viswanathan et al., 2008) . Additionally, mouse Lin41 has been shown to suppress let-7 activity, at least in part, by antagonizing Argonaute 2 (Rybak et al., 2009) . Considering the importance of the control of miRNA biogenesis, identification of proteins that regulate biogenesis of other lineage-specific miRNAs, such as miR-134, miR-145, miR-296, in ES cells is expected to provide greater insight into ES cell biology.
Additionally, a recent study demonstrated that the inhibitory effect of Lin28 on miRNA processing is not limited to let-7. Processing of several other miRNAs, including miR-107, miR-143, and miR-200c, is also inhibited by Lin28 (Heo et al., 2009 ). In accordance with this finding, miR-107, miR-143, and miR-200c are more abundantly expressed in differentiated cells compared to undifferentiated cells (Heo et al., 2009) . Therefore, additional studies to investigate the effects of these miRNAs on the fate of ES cells are warranted.
Roles of miRNAs in the reprogramming of somatic cells into iPS cells
Only four years ago, it was discovered that somatic cells could be reprogrammed into iPS cells (Takahashi and Yamanaka, 2006) . This brought about a true paradigm shift in the field of stem cell biology. Over the past four years, the original combination of reprogramming factors [Sox2, Oct4, Klf4, and c-Myc (SOKM)] has been used to generate iPS cells from a wide-range of cell types (Maherali and Hochedlinger, 2008; Cox and Rizzino, 2010) . Other combinations, such as Sox2, Oct4, Lin28 and Nanog, have also been used to generate iPS cells (Yu et al., 2007) . However, relatively little is known about the roles played by miRNAs in the reprogramming of somatic cells into iPS cells. The known effects of miRNAs during reprogramming and several examples of miRNAs with potential roles in modulating reprogramming are summarized in Fig. 3 .
Expression of ES cell-specific miRNAs promotes reprogramming
As discussed earlier, transient transfection of ESCC miRNAs into DGCR8 knockout mouse ES cells rescued their proliferation defect . Interestingly, Judson et al. investigated the effects of ESCC miRNAs on reprogramming of somatic cells into iPS cells (Judson et al., 2009) . For this purpose, mouse embryonic fibroblasts were infected with retroviruses that express Sox2, Oct4, and Klf4, and miRNA mimics were introduced into the cells by transient transfection. They determined that ESCC miRNAs increase the generation of mouse iPS cells induced by the combination of Sox2, Oct4, and Klf4. Among different ESCC miRNAs, miR-294 exhibited the greatest effect on reprogramming and increased efficiency of iPS cell generation from 0.01-0.05% to 0.4-0.7%. Additionally, miR-294 increased the kinetics of Sox2, Oct4, and Klf4 mediated reprogramming. However, when miR-294 was introduced with Sox2, Oct4, Klf4, and c-Myc, it had no effect on reprogramming. Therefore, ESCC miRNAs appear to promote Sox2, Oct4, and Klf4 mediated reprogramming by substituting for c-Myc. Importantly, iPS cells generated without c-Myc are likely to be safer for future use in cell-based clinical therapies. As discussed below, miRNAs from the miR-302 cluster have also been shown to promote reprogramming.
Inhibition of tissue-specific miRNAs promotes the formation of iPS cells
The pro-differentiation effect of let-7 on ES cells prompted Melton et al. to test the effect of inhibiting the activity of let-7 miRNA on the reprogramming of somatic cells into iPS cells (Marson et al., 2008; Rybak et al., 2008; Melton et al., 2010) . For this purpose, they introduced let-7 antisense inhibitor into mouse embryonic fibroblasts by transient transfection and studied its effects on reprogramming mediated by Sox2, Oct4, and Klf4, in the presence or absence of c-Myc. They determined that inhibition of let-7 activity increased Sox2, Oct4, and Klf4 mediated reprogramming 4.3 fold, whereas Sox2, Oct4, Klf4, and c-Myc-mediated reprogramming increased only 1.75 fold. These data argue that increased reprogramming in response to let-7 inhibition is mediated by let-7 target genes, such as c-Myc and Lin28 (Fig. 2) . Interestingly, recent studies have shown that Lin28 is also repressed by miR-125, which is abundantly expressed in differentiated cells (Wu and Belasco, 2005; Wilson et al., 2009 ). This raises the possibility that inhibiting the activity of both miR-125 and let-7 miRNAs may result in additional beneficial effects during reprogramming, due to robust activation of Lin28 expression. However, elevating Lin28 levels beyond a critical level could have deleterious effects (Darr and Benvenisty, 2009 ). Collectively, these results illustrate the important roles played by miRNAs in reprogramming somatic cells into iPS cells.
Mechanisms for modulating the activities and levels of miRNAs
Multiple methods are available to modulate the activities and levels of miRNAs. Anti-miRNA oligonucleotides, known as antagomirs, are routinely used to inhibit miRNA activity (Liu et al., 2008) . Antagomirs bind to mature miRNAs, mediated by Watson-Crick base pairing, and interfere with their target recognition. The affinity, stability, safety and delivery of antagomirs have been improved through chemical modifications. Four chemical modifications are commonly used: replacement of the 2′-OH in the ribose moiety with 2′-O-methyl or 2′-O-methoxyethyl, addition of an extra methylene bridge to the ribose moiety, and replacement of a non-bridging oxygen with a sulfur atom in the phosphate backbone (Wahlestedt et al., 2000; Meister et al., 2004; Davis et al., 2006; Orom et al., 2006; Liu et al., 2008) . Antagomirs are delivered to cells by transient transfection. Therefore, achieving efficient delivery and stable expression of these oligonucleotides is not possible. This shortcoming of antagomirs can be overcome by using viral vectors that code for miRNA sponges, which can provide efficient delivery and stable expression of anti-miRNAs (Gentner et al., 2009) . miRNA sponges are RNA molecules that contain multiple miRNA binding sites (Ebert et al., 2007) , and function by sequestering corresponding miRNAs. miRNA sponges often inhibit the activity of closely related miRNAs within the same family (Ebert et al., 2007) . In addition to inhibiting miRNA activity by various methods, one can exogenously express miRNAs by transient transfection of either miRNA mimics or pre-miRNAs (Tay et al., 2008a; Judson et al., 2009; Sengupta et al., 2009; Xu et al., 2009b; Melton et al., 2010) . Alternatively, exogenous miRNA expression can be achieved by viral vector-mediated delivery of pre-miRNA molecules, which provide both efficient delivery and stable expression of miRNAs (Lin et al., 2008; Xu et al., 2009b) .
Recent studies investigating the roles of miRNAs during reprogramming employed transient transfection of cells with miRNA mimics and miRNA inhibitors (Judson et al., 2009; Melton et al., 2010) . It is possible that longer expression of miRNA mimics and miRNA inhibitors, for example by using viral vectors, may be necessary to maximize their effects on reprogramming. However, stable expression of miRNA mimics and miRNA inhibitors that are helpful during somatic cell reprogramming may interfere with subsequent lineage-specific differentiation of the iPS cells. This problem can be circumvented by using drug-inducible viral vectors. Moving forward, it would also be desirable to employ methods, such as adenoviral vectors (Stadtfeld et al., 2008) or non-integrating episomal vectors , that deliver miRNA mimics and miRNA inhibitors without directly altering chromosomal integrity.
Do miRNAs mediate the effects of p53 on reprogramming?
Considering the burgeoning role of miRNAs in regulating ES cell self-renewal and differentiation, it is conceivable that miRNAs have much wider and more important roles in reprogramming than is currently recognized. Recent studies have shown that p53 poses a barrier to reprogramming, and deletion of p53 significantly increases (Melton et al., 2010) . miR-125, which inhibits the expression of Lin28, is also expected to positively influence reprogramming (Wu and Belasco, 2005) . Additionally, miRNAs that target specific signaling pathways (e.g. TFG-beta signaling) and epigenetic processes (e.g. DNA methylation) can also be tested for their ability to promote reprogramming. miRNAs encoded by Dlk1-Dio3 gene cluster are also attractive candidates for promoting reprogramming because activation of imprinted Dlk1-Dio3 gene cluster is essential for generating fully reprogrammed iPS cells, which are functionally equivalent to ES cells. Note: data were compiled from studies involving mouse and human cells.
the efficiency of generating iPS cells (Banito et al., 2009; Hong et al., 2009; Kawamura et al., 2009; Li et al., 2009; Marion et al., 2009) . Moreover, the effects of p53 on reprogramming appear to be mediated, at least in part, by p21. Accordingly, knock-down of p21 in cells containing wild-type p53 also increases the efficiency of generating iPS cells (Kawamura et al., 2009; Li et al., 2009 ). However, inhibition of the p53 pathway results in iPS cell populations containing a high percentage of cells with DNA damage (Marion et al., 2009) . To overcome the p53-mediated barrier to reprogramming without compromising the genomic integrity of iPS cells, it is necessary to understand the mechanisms by which p53 antagonizes reprogramming. A probable role for miRNAs in the p53-mediated barrier to reprogramming is suggested by the finding that p53 enhances the processing and maturation of several miRNAs in human fibroblasts, including miR-145 . Additionally, p53 has been shown to bind to the miR-145 promoter and activate its expression (Sachdeva et al., 2009) . As mentioned earlier, miR-145 induces ES cell differentiation by inhibiting the expression of key pluripotency/reprogramming factors, such as Sox2, Oct4, Klf4, and c-Myc (Sachdeva et al., 2009; Xu et al., 2009b) . Hence, it is reasonable to speculate that the p53-mediated barrier to reprogramming may be due, at least in part, to miR-145. If this is the case, inhibiting the activity of miR-145 will promote the reprogramming of human somatic cells into iPS cells by enabling the early activation of endogenous reprogramming factors. Furthermore, p53 positively regulates the expression of several miRNAs, in addition to miR-145 ). Therefore, it is possible that the effects of p53 on reprogramming are mediated through multiple miRNAs. Further study into the possible roles of p53-regulated miRNAs may identify still other roles for these non-coding RNAs.
Possible role for miRNAs in promoting epigenetic modifications that favor reprogramming
During generation of iPS cells a significant portion of the cells are trapped in partially reprogrammed states characterized by incomplete epigenetic remodeling involving persistent DNA hypermethylation at the promoters of pluripotency-associated genes (Mikkelsen et al., 2008) . One way to improve reprogramming efficiency could be to coax partially reprogrammed cells to undergo complete reprogramming. In support of this argument, inhibition or knock-down of DNA methyltransferase enhanced iPS cell generation by inducing promoter demethylation of pluripotency-associated genes (Mikkelsen et al., 2008) . Additionally, Dnmt inhibitors are also used to generate iPS cells with only two factors (Oct4 and Klf4) or three factors (Sox2, Oct4, and Klf4) (Huangfu et al., 2008; Shi et al., 2008) . Recently, miR-29b has been shown to induce global DNA hypomethylation and re-expression of p15 INK4b , a tumor suppressor gene, in human acute myeloid leukemia (AML) cells by targeting Dnmt 1, 3a, and 3b (Garzon et al., 2009) . Therefore, co-expression of miR-29b and reprogramming factors is expected to induce complete reprogramming of partially reprogrammed cells by promoting demethylation of promoter regions of pluripotency-associated genes, such as Oct4 and Nanog. It will be interesting to compare the effects of miR-29b and Dnmt knock-down (or Dnmt inhibitors) on reprogramming.
Recently, two independent studies have demonstrated that expression of the imprinted Dlk1-Dio3 gene cluster, which codes for ∼50 conserved miRNAs, is often silenced in iPS cells (Liu et al., 2010; Stadtfeld et al., 2010) . Moreover, treatment of iPS cells with HDAC inhibitors led to activation of the Dlk1-Dio3 miRNA cluster and the generation of iPS cells whose developmental potential appears to be equivalent to that of ES cells (Stadtfeld et al., 2010) . These findings highlight the importance of achieving the appropriate epigenetic status of cells during reprogramming, and further reinforce the critical roles played by miRNAs in the establishment and maintenance of pluripotency. Investigating the effects of exogenous expression of individual miRNAs encoded by the Dlk1-Dio3 cluster during reprogramming will provide further insight into the specific roles of this miRNA cluster.
miRNAs as modulators of pluripotency-promoting signaling pathways during reprogramming
Signaling pathways involved in regulation of a multitude of cellular functions play essential roles in relaying external cues to cells. Among the different pluripotency-sustaining signaling pathways, significant progress has been made towards understanding the roles of TGF-β/Activin signaling in human ES cells Vallier et al., 2009 ). Inhibition of TGF-β/Activin signaling using a chemical inhibitor induces human ES cells to differentiate (James et al., 2005) . TGF-β signaling is activated when Activin binds to the ALK4 receptor leading to phosphorylation of SMAD 2/3. Phosphorylated SMAD 2/3 binds to SMAD4 and the resulting complex associates with the promoters of its target genes to activate their expression . Recent work has shown that SMAD 2/3 complex binds to SMAD binding elements (SBE) in the Nanog promoter and activates its expression in human ES cells Vallier et al., 2009) . miRNAs that inhibit TGF-β signaling have been identified in different cell types. In mouse liver stem cells, miR-23b and miR-24-1 inhibit TGF-β signaling by downregulating SMAD3 (Rogler et al., 2009) . In human haematopoietic progenitor cells, miR-24-1 inhibits TGF-β/Activin signaling by targeting the ALK4 receptor (Wang et al., 2008a) . miR-21 induces adipogenic differentiation of human adipose tissue derived mesenchymal stem cells by downregulating the expression of the type II TGF-β receptor (Kim et al., 2009d) . Additionally, miRNA profiling experiments have shown that miR-24-1, miR-23b, and miR-21 are expressed at high levels in human IMR90 fibroblasts, whereas their expression is significantly lower in human ES cells and iPS cells generated from IMR90 fibroblasts (Wilson et al., 2009 ). This suggests that inhibiting the activity of miR-24-1, miR-23b, and miR-21 may promote reprogramming of human somatic cells into human iPS cells by activating TGF-β/Activin signaling. Apart from its role in regulating TGF-β signaling, miR-24-1 also inhibits cell proliferation by targeting important cell cycle regulators, such as c-Myc, and E2F2 (Lal et al., 2009) . By inhibiting the activity of miR-24-1, it may be possible to generate iPS cells without c-Myc and Klf4. In this regard, c-Myc and Klf4 appear to promote reprogramming, at least in part, by increasing cellular proliferation (Yamanaka., 2007) . Apart from the miRNAs discussed above, it will be important to identify and study miRNAs that modulate other signaling pathways, such as Wnt and Mek/Erk, in the process of reprogramming. Again, it is important to recognize that different signaling pathways control the self-renewal and pluripotency of human and mouse ES cells .
c-Myc induced miRNAs and miRNAs involved in regulation of ES cell self-renewal and cell cycle progression as promoters of reprogramming
As mentioned earlier, c-Myc-regulated miRNAs, miR-141, miR-200, and miR-429, have been shown to attenuate differentiation of mouse ES cells upon LIF withdrawal . Additionally, the pro-tumorigenic miR-17-92 cluster, which is transcriptionally activated by c-Myc in tumor cell models, is enriched in both human ES cells and human iPS cells (O'Donnell et al., 2005; Wilson et al., 2009 ). Hence, it would be interesting to determine whether these c-Mycregulated miRNAs exert positive effects on somatic cell reprogramming. Similarly, miR-92b and miRNAs belonging to the miR-520 cluster should be tested for their effects on reprogramming given their established or predicted roles in promoting ES cell proliferation (Ren et al., 2009; Sengupta et al., 2009 ). In addition, inhibitors of miR-134, miR-296 and miR-470 miRNAs appear to be good candidates for influencing reprogramming, given that these miRNAs have been shown to interfere with the self-renewal of ES cells (Tay et al., 2008a) .
Finally, various miRNA mimics and miRNA inhibitors, when used in the optimal combination with one another, are expected to improve both the efficiency of producing iPS cells and the quality of the iPS cells produced. Interestingly, it has been reported that reprogramming of tumor cells can be achieved using only miRNAs, specifically by exogenous expression of the miR-302 cluster (Lin et al., 2008) . Furthermore, it was claimed that the miR-302 cluster can also reprogram primary cultured somatic cells, but no data was presented (Lin et al., 2008) . Thus, the potential clinical use of human iPS cells generated solely with miRNAs remains to be determined. Furthermore, the effectiveness of miRNA-based reprogramming strategies may be cell-type dependent. From an experimental standpoint, it would be interesting to test the ability of the miRNAs, including the miR-302 cluster, to reprogram neural stem cells, which only require Oct4 for reprogramming (Kim et al., 2009a; Kim et al., 2009b) .
Conclusion
Research over the past decade has contributed substantially towards understanding the molecular mechanisms that control self-renewal and pluripotency of ES cells. The identification of miRNAs and their varied effects on ES cells has provided a far better understanding of the molecular mechanisms that fine tune the complex gene regulatory networks which control the proliferation and the differentiation of pluripotent stem cells. Specific miRNAs, both ES cell-and tissue-specific, have been shown to regulate the expression of critical transcription factors, cell cycle proteins, epigenetic modifiers, and other regulatory proteins, to confer either ES cell or differentiated cell phenotypes. Notwithstanding the immense progress made recently towards understanding the contribution of miRNAs in maintaining the pluripotent state, much remains to be done. Recent work by several groups have demonstrated that iPS cells and ES cells can be distinguished by gene expression signatures, including expression of miRNAs (Chin et al., 2009; Liu et al., 2010; Stadtfeld et al., 2010) . These findings suggest that iPS cells are very similar to ES cells, but there are important differences between them. Finally, as discussed in this review, our understanding of the roles of miRNAs in somatic cell reprogramming is relatively limited. Therefore, future studies that modulate the expression of specific miRNAs during the generation of iPS cells are expected to both improve reprogramming itself and provide greater insights into the mechanistic details surrounding the generation of iPS cells. Equally important, extensive characterization of the miRNA status of human iPS cells is likely to have significant impact on the potential clinical use of these cells in cell-based therapies.
